Synovial Sarcoma — Trials

Synovial Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

94 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 33
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 33%
Top sponsor: USWM CT, LLC
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04044768	Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma	active not recruiting	Phase 2	52	USWM CT, LLCINDUSTRY	5	Aug 26, 2026	clinicaltrials
NCT02650986	Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1	active not recruiting	Phase 1 / Phase 2	15	Roswell Park Cancer InstituteOTHER	1	Jul 8, 2026	clinicaltrials